Skip to main content
Top
Published in: Journal of Translational Medicine 1/2011

Open Access 01-12-2011 | Research

Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B

Authors: Jiezuan Yang, Jianqin He, Haifeng Lu, Li Wei, Sujun Li, Baohong Wang, Hongyan Diao, Lanjuan Li

Published in: Journal of Translational Medicine | Issue 1/2011

Login to get access

Abstract

Background

T cell receptor (TCR) reflects the status and function of T cells. We previously developed a gene melting spectral pattern (GMSP) assay, which rapidly detects clonal expansion of the T cell receptor β variable gene (TCRBV) in patients with HBV by using quantitative real-time reverse transcription PCR (qRT-PCR) with DNA melting curve analysis. However, the molecular profiles of TCRBV in peripheral blood mononuclear cells (PBMCs) and CD8+, CD8- cell subsets from chronic severe hepatitis B (CSHB) patients have not been well described.

Methods

Human PBMCs were separated and sorted into CD8+ and CD8- cell subsets using density gradient centrifugation and magnetic activated cell sorting (MACS). The molecular features of the TCRBV CDR3 motif were determined using GMSP analysis; the TCRBV families were cloned and sequenced when the GMSP profile showed a single-peak, indicative of a monoclonal population.

Results

The number of skewed TCRBV in the CD8+ cell subset was significantly higher than that of the CD8- cell subset as assessed by GMSP analysis. The TCRBV11 and BV7 were expressed more frequently than other members of TCRBV family in PBMCs and CD8+, CD8- subsets. Also the relatively conserved amino acid motifs were detected in the TCRBV22, BV18 and BV11 CDR3 in PBMCs among patients with CSHB.

Conclusions

The molecular features of the TCRBV CDR3 were markedly different among PBMCs and CD8+, CD8- cell subsets derived from CSHB patients. Analysis of the TCRBV expression in the CD8+ subset was more accurate in assessing the status and function of circulating T cells. The expression of TCRBV11, BV7 and the relatively conserved CDR3 amino acid motifs could also help to predict and treat patients with CSHB.
Appendix
Available only for authorised users
Literature
1.
go back to reference Organization WH: Department of Communicable diseases surveillance and response. Hepatitis B. Who Fact Sheets. 2004 Organization WH: Department of Communicable diseases surveillance and response. Hepatitis B. Who Fact Sheets. 2004
2.
go back to reference Liaw YF: Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int. 2009, 29 (Suppl 1): 100-107.CrossRefPubMed Liaw YF: Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int. 2009, 29 (Suppl 1): 100-107.CrossRefPubMed
3.
go back to reference Wei L: Natural history of chronic hepatitis B virus infection: what determines prognosis after cirrhotic decompensation?. J Gastroenterol Hepatol. 2008, 23: 1631-1632. 10.1111/j.1440-1746.2008.05576.x.CrossRefPubMed Wei L: Natural history of chronic hepatitis B virus infection: what determines prognosis after cirrhotic decompensation?. J Gastroenterol Hepatol. 2008, 23: 1631-1632. 10.1111/j.1440-1746.2008.05576.x.CrossRefPubMed
4.
go back to reference Miqueu P, Guillet M, Degauque N, Dore JC, Soulillou JP, Brouard S: Statistical analysis of CDR3 length distributions for the assessment of T and B cell repertoire biases. Mol Immunol. 2007, 44: 1057-1064. 10.1016/j.molimm.2006.06.026.CrossRefPubMed Miqueu P, Guillet M, Degauque N, Dore JC, Soulillou JP, Brouard S: Statistical analysis of CDR3 length distributions for the assessment of T and B cell repertoire biases. Mol Immunol. 2007, 44: 1057-1064. 10.1016/j.molimm.2006.06.026.CrossRefPubMed
5.
go back to reference Melenhorst JJ, Lay MDH, Price DA, Adams SD, Zeilah J, Sosa E, Hensel NF, Follmann D, Douek DC, Davenport MP, Barrett AJ: Contribution of TCR-β locus and HLA to the shape of the mature human Vβ repertoire. Journal of Immunology. 2008, 180: 6484-6489.CrossRef Melenhorst JJ, Lay MDH, Price DA, Adams SD, Zeilah J, Sosa E, Hensel NF, Follmann D, Douek DC, Davenport MP, Barrett AJ: Contribution of TCR-β locus and HLA to the shape of the mature human Vβ repertoire. Journal of Immunology. 2008, 180: 6484-6489.CrossRef
6.
go back to reference Porter DL, Levine BL, Kalos M, Bagg A, June CH: Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011, 365: 725-733. 10.1056/NEJMoa1103849.PubMedCentralCrossRefPubMed Porter DL, Levine BL, Kalos M, Bagg A, June CH: Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011, 365: 725-733. 10.1056/NEJMoa1103849.PubMedCentralCrossRefPubMed
7.
go back to reference Imamura T, Yokosuka O, Kurihara T, Kanda T, Fukai K, Imazeki F, Saisho H: Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan. Gut. 2003, 52: 1630-1637. 10.1136/gut.52.11.1630.PubMedCentralCrossRefPubMed Imamura T, Yokosuka O, Kurihara T, Kanda T, Fukai K, Imazeki F, Saisho H: Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan. Gut. 2003, 52: 1630-1637. 10.1136/gut.52.11.1630.PubMedCentralCrossRefPubMed
8.
go back to reference Chen Y, Li X, Ye B, Yang X, Wu W, Chen B, Pan X, Cao H, Li L: Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. Antiviral Res. 2011, 91: 23-31. 10.1016/j.antiviral.2011.04.008.CrossRefPubMed Chen Y, Li X, Ye B, Yang X, Wu W, Chen B, Pan X, Cao H, Li L: Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. Antiviral Res. 2011, 91: 23-31. 10.1016/j.antiviral.2011.04.008.CrossRefPubMed
9.
go back to reference Yang JZ, Li MW, Wang JG, Lu HF, Yao XS, He JQ, Li LJ: Rapid detection of clonal expansion of T-cell receptor-beta gene in patients with HBV using the real-time PCR with DNA melting curve analysis. Hepatol Res. 2010, 40: 407-414. 10.1111/j.1872-034X.2009.00600.x.CrossRefPubMed Yang JZ, Li MW, Wang JG, Lu HF, Yao XS, He JQ, Li LJ: Rapid detection of clonal expansion of T-cell receptor-beta gene in patients with HBV using the real-time PCR with DNA melting curve analysis. Hepatol Res. 2010, 40: 407-414. 10.1111/j.1872-034X.2009.00600.x.CrossRefPubMed
10.
go back to reference Yim HJ, Lok AS: Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006, 43: S173-181. 10.1002/hep.20956.CrossRefPubMed Yim HJ, Lok AS: Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology. 2006, 43: S173-181. 10.1002/hep.20956.CrossRefPubMed
11.
go back to reference McMahon BJ: The natural history of chronic hepatitis B virus infection. Hepatology. 2009, 49: S45-55. 10.1002/hep.22898.CrossRefPubMed McMahon BJ: The natural history of chronic hepatitis B virus infection. Hepatology. 2009, 49: S45-55. 10.1002/hep.22898.CrossRefPubMed
12.
go back to reference Komatsu H, Inui A, Sogo T, Hiejima E, Tateno A, Klenerman P, Fujisawa T: Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus. BMC Infect Dis. 2010, 10: 103-10.1186/1471-2334-10-103.PubMedCentralCrossRefPubMed Komatsu H, Inui A, Sogo T, Hiejima E, Tateno A, Klenerman P, Fujisawa T: Cellular immunity in children with successful immunoprophylactic treatment for mother-to-child transmission of hepatitis B virus. BMC Infect Dis. 2010, 10: 103-10.1186/1471-2334-10-103.PubMedCentralCrossRefPubMed
13.
go back to reference Kreslavsky T, Gleimer M, Garbe AI, von Boehmer H: alphabeta versus gammadelta fate choice: counting the T-cell lineages at the branch point. Immunol Rev. 2010, 238: 169-181. 10.1111/j.1600-065X.2010.00947.x.PubMedCentralCrossRefPubMed Kreslavsky T, Gleimer M, Garbe AI, von Boehmer H: alphabeta versus gammadelta fate choice: counting the T-cell lineages at the branch point. Immunol Rev. 2010, 238: 169-181. 10.1111/j.1600-065X.2010.00947.x.PubMedCentralCrossRefPubMed
14.
go back to reference Marrack P, Kappler J: Positive selection of thymocytes bearing alpha beta T cell receptors. Curr Opin Immunol. 1997, 9: 250-255. 10.1016/S0952-7915(97)80144-6.CrossRefPubMed Marrack P, Kappler J: Positive selection of thymocytes bearing alpha beta T cell receptors. Curr Opin Immunol. 1997, 9: 250-255. 10.1016/S0952-7915(97)80144-6.CrossRefPubMed
15.
go back to reference Okajima M, Wada T, Nishida M, Yokoyama T, Nakayama Y, Hashida Y, Shibata F, Tone Y, Ishizaki A, Shimizu M, Saito T, Ohta K, Toma T, Yachie A: Analysis of T cell receptor Vbeta diversity in peripheral CD4 and CD8 T lymphocytes in patients with autoimmune thyroid diseases. Clin Exp Immunol. 2009, 155: 166-172. 10.1111/j.1365-2249.2008.03842.x.PubMedCentralCrossRefPubMed Okajima M, Wada T, Nishida M, Yokoyama T, Nakayama Y, Hashida Y, Shibata F, Tone Y, Ishizaki A, Shimizu M, Saito T, Ohta K, Toma T, Yachie A: Analysis of T cell receptor Vbeta diversity in peripheral CD4 and CD8 T lymphocytes in patients with autoimmune thyroid diseases. Clin Exp Immunol. 2009, 155: 166-172. 10.1111/j.1365-2249.2008.03842.x.PubMedCentralCrossRefPubMed
16.
go back to reference Du JW, Gu JY, Liu J, Cen XN, Zhang Y, Ou Y, Chu B, Zhu P: TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma. 2007, 48: 1618-1627. 10.1080/10428190701474357.CrossRefPubMed Du JW, Gu JY, Liu J, Cen XN, Zhang Y, Ou Y, Chu B, Zhu P: TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma. 2007, 48: 1618-1627. 10.1080/10428190701474357.CrossRefPubMed
17.
go back to reference Spicuglia S, Pekowska A, Zacarias-Cabeza J, Ferrier P: Epigenetic control of Tcrb gene rearrangement. Semin Immunol. 2010, 22: 330-336. 10.1016/j.smim.2010.07.002.CrossRefPubMed Spicuglia S, Pekowska A, Zacarias-Cabeza J, Ferrier P: Epigenetic control of Tcrb gene rearrangement. Semin Immunol. 2010, 22: 330-336. 10.1016/j.smim.2010.07.002.CrossRefPubMed
18.
go back to reference Long SA, Khalili J, Ashe J, Berenson R, Ferrand C, Bonyhadi M: Standardized analysis for the quantification of Vbeta CDR3 T-cell receptor diversity. J Immunol Methods. 2006, 317: 100-113. 10.1016/j.jim.2006.09.015.CrossRefPubMed Long SA, Khalili J, Ashe J, Berenson R, Ferrand C, Bonyhadi M: Standardized analysis for the quantification of Vbeta CDR3 T-cell receptor diversity. J Immunol Methods. 2006, 317: 100-113. 10.1016/j.jim.2006.09.015.CrossRefPubMed
19.
go back to reference Pilch H, Hohn H, Freitag K, Neukirch C, Necker A, Haddad P, Tanner B, Knapstein PG, Maeurer MJ: Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis. Clin Diagn Lab Immunol. 2002, 9: 257-266.PubMedCentralPubMed Pilch H, Hohn H, Freitag K, Neukirch C, Necker A, Haddad P, Tanner B, Knapstein PG, Maeurer MJ: Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis. Clin Diagn Lab Immunol. 2002, 9: 257-266.PubMedCentralPubMed
20.
go back to reference Ochsenreither S, Fusi A, Busse A, Nagorsen D, Schrama D, Becker J, Thiel E, Keilholz U: Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations. J Transl Med. 2008, 6: 34-10.1186/1479-5876-6-34.PubMedCentralCrossRefPubMed Ochsenreither S, Fusi A, Busse A, Nagorsen D, Schrama D, Becker J, Thiel E, Keilholz U: Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations. J Transl Med. 2008, 6: 34-10.1186/1479-5876-6-34.PubMedCentralCrossRefPubMed
21.
go back to reference Seo KS, Park JY, Terman DS, Bohach GA: A quantitative real time PCR method to analyze T cell receptor Vbeta subgroup expansion by staphylococcal superantigens. J Transl Med. 2010, 8: 2-10.1186/1479-5876-8-2.PubMedCentralCrossRefPubMed Seo KS, Park JY, Terman DS, Bohach GA: A quantitative real time PCR method to analyze T cell receptor Vbeta subgroup expansion by staphylococcal superantigens. J Transl Med. 2010, 8: 2-10.1186/1479-5876-8-2.PubMedCentralCrossRefPubMed
22.
go back to reference Sun W, Nie H, Li N, Zang YC, Zhang D, Feng G, Ni L, Xu R, Prasad S, Robinson RR, Ho W, Sercarz E, Zhang JZ: Skewed T-cell receptor BV14 and BV16 expression and shared CDR3 sequence and common sequence motifs in synovial T cells of rheumatoid arthritis. Genes Immun. 2005, 6: 248-261. 10.1038/sj.gene.6364166.CrossRefPubMed Sun W, Nie H, Li N, Zang YC, Zhang D, Feng G, Ni L, Xu R, Prasad S, Robinson RR, Ho W, Sercarz E, Zhang JZ: Skewed T-cell receptor BV14 and BV16 expression and shared CDR3 sequence and common sequence motifs in synovial T cells of rheumatoid arthritis. Genes Immun. 2005, 6: 248-261. 10.1038/sj.gene.6364166.CrossRefPubMed
23.
go back to reference Das A, Hoare M, Davies N, Lopes AR, Dunn C, Kennedy PT, Alexander G, Finney H, Lawson A, Plunkett FJ, Bertoletti A, Akbar AN, Maini MK: Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med. 2008, 205: 2111-2124. 10.1084/jem.20072076.PubMedCentralCrossRefPubMed Das A, Hoare M, Davies N, Lopes AR, Dunn C, Kennedy PT, Alexander G, Finney H, Lawson A, Plunkett FJ, Bertoletti A, Akbar AN, Maini MK: Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med. 2008, 205: 2111-2124. 10.1084/jem.20072076.PubMedCentralCrossRefPubMed
24.
go back to reference Kerkar SP, Sanchez-Perez L, Yang S, Borman ZA, Muranski P, Ji Y, Chinnasamy D, Kaiser AD, Hinrichs CS, Klebanoff CA, Scott CD, Gattinoni L, Morgan RA, Rosenberg SA, Restifo NP: Genetic engineering of murine CD8(+) and CD4(+) T cells for preclinical adoptive immunotherapy studies. J Immunother. 2011, 34: 343-352. 10.1097/CJI.0b013e3182187600.PubMedCentralCrossRefPubMed Kerkar SP, Sanchez-Perez L, Yang S, Borman ZA, Muranski P, Ji Y, Chinnasamy D, Kaiser AD, Hinrichs CS, Klebanoff CA, Scott CD, Gattinoni L, Morgan RA, Rosenberg SA, Restifo NP: Genetic engineering of murine CD8(+) and CD4(+) T cells for preclinical adoptive immunotherapy studies. J Immunother. 2011, 34: 343-352. 10.1097/CJI.0b013e3182187600.PubMedCentralCrossRefPubMed
25.
go back to reference Bendle GM, Haanen JB, Schumacher TN: Preclinical development of T cell receptor gene therapy. Curr Opin Immunol. 2009, 21: 209-214. 10.1016/j.coi.2009.02.007.CrossRefPubMed Bendle GM, Haanen JB, Schumacher TN: Preclinical development of T cell receptor gene therapy. Curr Opin Immunol. 2009, 21: 209-214. 10.1016/j.coi.2009.02.007.CrossRefPubMed
26.
go back to reference A V-R: Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med. 2008, 14: 1390-1395. 10.1038/nm.1779.CrossRef A V-R: Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nat Med. 2008, 14: 1390-1395. 10.1038/nm.1779.CrossRef
27.
go back to reference Wang QJ, Hanada K, Feldman SA, Zhao Y, Inozume T, Yang JC: Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma. J Immunol Methods. 2011, 366: 43-51. 10.1016/j.jim.2011.01.002.PubMedCentralCrossRefPubMed Wang QJ, Hanada K, Feldman SA, Zhao Y, Inozume T, Yang JC: Development of a genetically-modified novel T-cell receptor for adoptive cell transfer against renal cell carcinoma. J Immunol Methods. 2011, 366: 43-51. 10.1016/j.jim.2011.01.002.PubMedCentralCrossRefPubMed
28.
go back to reference Frankel TL, Burns WR, Peng PD, Yu Z, Chinnasamy D, Wargo JA, Zheng Z, Restifo NP, Rosenberg SA, Morgan RA: Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase. J Immunol. 2010, 184: 5988-5998. 10.4049/jimmunol.1000189.CrossRefPubMed Frankel TL, Burns WR, Peng PD, Yu Z, Chinnasamy D, Wargo JA, Zheng Z, Restifo NP, Rosenberg SA, Morgan RA: Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase. J Immunol. 2010, 184: 5988-5998. 10.4049/jimmunol.1000189.CrossRefPubMed
29.
go back to reference Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA: Cancer regression in patients after transfer of genetically engineered lymphocytes. Science. 2006, 314: 126-129. 10.1126/science.1129003.PubMedCentralCrossRefPubMed Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, Royal RE, Topalian SL, Kammula US, Restifo NP, Zheng Z, Nahvi A, de Vries CR, Rogers-Freezer LJ, Mavroukakis SA, Rosenberg SA: Cancer regression in patients after transfer of genetically engineered lymphocytes. Science. 2006, 314: 126-129. 10.1126/science.1129003.PubMedCentralCrossRefPubMed
30.
go back to reference Gehring AJ, Xue SA, Ho ZZ, Teoh D, Ruedl C, Chia A, Koh S, Lim SG, Maini MK, Stauss H, Bertoletti A: Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J Hepatol. 2011, 55: 103-110. 10.1016/j.jhep.2010.10.025.CrossRefPubMed Gehring AJ, Xue SA, Ho ZZ, Teoh D, Ruedl C, Chia A, Koh S, Lim SG, Maini MK, Stauss H, Bertoletti A: Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J Hepatol. 2011, 55: 103-110. 10.1016/j.jhep.2010.10.025.CrossRefPubMed
31.
go back to reference Jorritsma A, Schotte R, Coccoris M, de Witte MA, Schumacher TN: Prospects and limitations of T cell receptor gene therapy. Curr Gene Ther. 2011, 11: 276-287. 10.2174/156652311796150390.CrossRefPubMed Jorritsma A, Schotte R, Coccoris M, de Witte MA, Schumacher TN: Prospects and limitations of T cell receptor gene therapy. Curr Gene Ther. 2011, 11: 276-287. 10.2174/156652311796150390.CrossRefPubMed
32.
go back to reference Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L, Cheung SK, Wong WM, Lau GK: Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology. 2007, 46: 395-401.CrossRefPubMed Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L, Cheung SK, Wong WM, Lau GK: Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology. 2007, 46: 395-401.CrossRefPubMed
Metadata
Title
Molecular features of the complementarity determining region 3 motif of the T cell population and subsets in the blood of patients with chronic severe hepatitis B
Authors
Jiezuan Yang
Jianqin He
Haifeng Lu
Li Wei
Sujun Li
Baohong Wang
Hongyan Diao
Lanjuan Li
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2011
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-9-210

Other articles of this Issue 1/2011

Journal of Translational Medicine 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.